120 related articles for article (PubMed ID: 17134859)
1. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
2. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
Schiffelers RM; Ansari A; Xu J; Zhou Q; Tang Q; Storm G; Molema G; Lu PY; Scaria PV; Woodle MC
Nucleic Acids Res; 2004 Nov; 32(19):e149. PubMed ID: 15520458
[TBL] [Abstract][Full Text] [Related]
3. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.
Elzeny H; Zhang F; Ali EN; Fathi HA; Zhang S; Li R; El-Mokhtar MA; Hamad MA; Wooley KL; Elsabahy M
Drug Des Devel Ther; 2017; 11():483-496. PubMed ID: 28260861
[TBL] [Abstract][Full Text] [Related]
4. Biologically responsive carrier-mediated anti-angiogenesis shRNA delivery for tumor treatment.
Che J; Tao A; Chen S; Li X; Zhao Y; Yuan W
Sci Rep; 2016 Oct; 6():35661. PubMed ID: 27759095
[TBL] [Abstract][Full Text] [Related]
5. Amylose-Based Cationic Star Polymers for siRNA Delivery.
Nishimura T; Umezaki K; Mukai SA; Sawada S; Akiyoshi K
Biomed Res Int; 2015; 2015():962941. PubMed ID: 26539548
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposome-nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing.
Majzoub RN; Ewert KK; Safinya CR
Philos Trans A Math Phys Eng Sci; 2016 Jul; 374(2072):. PubMed ID: 27298431
[TBL] [Abstract][Full Text] [Related]
7. Cationic Nanoparticles Assembled from Natural-Based Steroid Lipid for Improved Intracellular Transport of siRNA and pDNA.
Sheng R; Zhuang X; Wang Z; Cao A; Lin K; Zhu JX
Nanomaterials (Basel); 2016 Apr; 6(4):. PubMed ID: 28335197
[TBL] [Abstract][Full Text] [Related]
8. Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy.
Qin Y; Rouatbi N; Wang JT; Baker R; Spicer J; Walters AA; Al-Jamal KT
J Control Release; 2024 May; 369():251-265. PubMed ID: 38493950
[TBL] [Abstract][Full Text] [Related]
9. Targeting HPV-infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine.
Levine RM; Dinh CV; Harris MA; Kokkoli E
Bioeng Transl Med; 2016 Jun; 1(2):168-180. PubMed ID: 29313012
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Tomography Studies of the Biodistribution, Translocation, and Fate of Poly Allyl Amine-Based Carriers for Sirna Delivery by Systemic and Intratumoral Administration.
Simo C; Salvador C; Andreozzi P; Gomez-Vallejo V; Romero G; Dupin D; Llop J; Moya SE
Small; 2023 Nov; 19(48):e2304326. PubMed ID: 37537708
[TBL] [Abstract][Full Text] [Related]
11. siRNA delivery to the lung: what's new?
Merkel OM; Rubinstein I; Kissel T
Adv Drug Deliv Rev; 2014 Aug; 75():112-28. PubMed ID: 24907426
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeted siRNA delivery by adenosine receptor-specific curdlan nanoparticles.
Bao Q; Ganbold T; Bao M; Xiao H; Han S; Baigude H
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126845. PubMed ID: 37703972
[TBL] [Abstract][Full Text] [Related]
13. Innovative System for Delivering Nucleic Acids/Genes Based on Controlled Intracellular Trafficking as Well as Controlled Biodistribution for Nanomedicines.
Harashima H
Biol Pharm Bull; 2023; 46(12):1648-1660. PubMed ID: 38044089
[TBL] [Abstract][Full Text] [Related]
14. Cationic cycloamylose based nucleic acid nanocarriers.
Prasher P; Sharma M; Agarwal V; Singh SK; Gupta G; Dureja H; Dua K
Chem Biol Interact; 2024 May; 395():111000. PubMed ID: 38614318
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Cationic Nanoparticles as Carriers of Antiviral Nucleic Acids.
Jadaa N; Aldor N; Jenik K; Oberhoffner S; Butkowsky C; Tran A; Lewis A; DeWitte-Orr SJ; Poynter S
Methods Mol Biol; 2024; 2813():309-320. PubMed ID: 38888786
[TBL] [Abstract][Full Text] [Related]
16. ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.
Malefyt AP; Walton SP; Chan C
Nano Life; 2012 Sep; 2(3):1241005. PubMed ID: 23956796
[TBL] [Abstract][Full Text] [Related]
17.
Äärelä A; Auchynnikava T; Moisio O; Liljenbäck H; Andriana P; Iqbal I; Lehtimäki J; Rajander J; Salo H; Roivainen A; Airaksinen AJ; Virta P
Mol Pharm; 2023 Oct; 20(10):5043-5051. PubMed ID: 37531591
[No Abstract] [Full Text] [Related]
18. The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.
Izci M; Maksoudian C; Manshian BB; Soenen SJ
Chem Rev; 2021 Feb; 121(3):1746-1803. PubMed ID: 33445874
[TBL] [Abstract][Full Text] [Related]
19. Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA.
Zheng QC; Jiang S; Wu YZ; Shang D; Zhang Y; Hu SB; Cheng X; Zhang C; Sun P; Gao Y; Song ZF; Li M
Front Bioeng Biotechnol; 2020; 8():512. PubMed ID: 32587849
[TBL] [Abstract][Full Text] [Related]
20. Structure-Dependent Biodistribution of Liposomal Spherical Nucleic Acids.
Ferrer JR; Sinegra AJ; Ivancic D; Yeap XY; Qiu L; Wang JJ; Zhang ZJ; Wertheim JA; Mirkin CA
ACS Nano; 2020 Feb; 14(2):1682-1693. PubMed ID: 31951368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
